| Cat.No. | Name | Information |
|---|---|---|
| M50228 | Carbetocin acetate | Carbetocin acetate is an oxytocin (OT) analog and oxytocin receptor agonist that crosses the blood-brain barrier with a Ki of 7.1 nM. In addition, Carbetocin acetate has a high affinity for the chimeric N-terminal (E1) end of the oxytocin receptor, with a Ki = 1.17 μM. Carbetocin acetate can be used in studies related to postpartum hemorrhage. |
| M30861 | Atosiban | Atosiban (RW22164; RWJ22164) is a nonapeptide competitive vasopressin/oxytocin receptor antagonist, and is a desamino-oxytocin analogue. Atosiban is the main tocolytic agent and has the potential for spontaneous preterm labor research. |
| M14040 | L-368,899 hydrochloride | L-368,899 hydrochloride is a potent, selective, orally bioavailable, non-peptide oxytocin receptor antagonist, with IC50s of 8.9 nM and 26 nM for rat uterus and human uterus oxytocin receptor, respectively. |
| M9193 | Carbetocin | Carbetocin is an oxytocin receptor agonist with a Ki of 7.1 nM. Carbetocin can crosse the blood-brain barrier and produces antidepressant-like activity via activation of oxytocin receptors in the CNS. |
| M9064 | Oxytocin acetate | Oxytocin acetate, a mammalian neurohypophysial hormone, is a pleiotropic, hypothalamic peptide known for facilitating parturition, lactation, and prosocial behaviors. Oxytocin acetate can function as a stress-coping molecule with anti-inflammatory, antioxidant, and protective effects especially in the face of adversity or trauma. |
| M3777 | Cligosiban | Cligosiban (PF-3274167) is a high-affinity, high oral bioavailability and good brain-penetrant nonpeptide oxytocin receptor (OTR) antagonist, with Ki of 9.5 nM. |
| M54235 | [Asp5]-Oxytocin | [Asp5]-Oxytocin is the first 5-position neurohypophyseal hormone analogue possessing significant biological activity. |
| M52938 | (d(CH2)51, Tyr(Me)2, Thr4, Orn8, Tyr-NH29)-Vasotocin | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,Tyr-NH29)-Vasotocin is an oxytocin antagonist and can be used for the research of sexual behavior. |
| M52937 | (d(CH2)51, Tyr(Me)2, Orn8)-Oxytocin | (d(CH2)51,Tyr(Me)2,Orn8)-Oxytocin (OVT) is an oxytocin receptor antagonist. |
| M52936 | (Val3, Pro8)-Oxytocin | (Val3,Pro8)-Oxytocin is the Gq-dependent pathway agonist. |
| M52935 | (d(CH2)51, Tyr(Me)2, Thr4, Orn8, des-Gly-NH29)-Vasotocin | (d(CH2)51,Tyr(Me)2,Thr4,Orn8,des-Gly-NH29)-Vasotocin, an oxytocin receptor antagonist, abolishes oxytocin-enhanced inhibitory postsynaptic currents in CA1 pyramidal neurons. |
| M52934 | Demoxytocin | Demoxytocin, a heterodetic cyclic peptide, is an analog of oxytocin. |
| M52933 | Cargutocin | Cargutocin, an oxytocin analogue, targets the oxytocin receptor and acts as a uterine contraction agent. |
| M52932 | Barusiban | Barusiban (FE-200440) is an oxytocin receptor (OT-R) antagonist (Ki=0.8 nM), inhibits OT-induced contraction. |
| M52931 | L-366682 | L-366682, a cyclic hexapeptide, possesses antagonism of oxytocin. |
| M41900 | Pro8-Oxytocin | Pro8-Oxytocin is a a modified oxytocin (OXT) ligand. |
| M41899 | Pro8-Oxytocin TFA | Pro8-Oxytocin TFA is a a modified oxytocin (OXT) ligand. |
| M30776 | Epelsiban | Epelsiban (GSK 557296) is a potent, selective and orally bioavailable oxytocin receptor antagonist, with a pKi of 9.9 for human oxytocin receptor. |
| M30147 | TC OT 39 | TC OT 39 is a synthetic oxytocin analog, as well as a selective agonist of oxytocin receptor (OXTR, EC50=180 nM). TC OT 39 is also an Avprla vasopressin receptor antagonist with an Ki value of 330 nM. TC OT 39 exhibits sedative effects in mouse models. |
| M29995 | OT-R antagonist 1 | OT-R antagonist 1 is a new potent and selective nonpeptide low molecular weight OT-R antagonist. OT-R antagonist 1 inhibits oxytocin-evoked intracellular Ca2+ mobilization (IC50 = 8 nM). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
